We are live on ! Find out more
CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+17.37%
3 Year Est. Return
+18.06%
5 Year Est. Return
+62.97%
10 Year Est. Return
AUM
$1.76B
AUM Growth
+$123M
Cap. Flow
+$30.5M
Cap. Flow %
1.73%
Top 10 Hldgs %
20.53%
Holding
2,523
New
97
Increased
920
Reduced
750
Closed
126
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMH icon
651
VanEck Semiconductor ETF
SMH
$65.2B
$255K 0.01%
1,650
+1,384
+520% +$200K
MRNA icon
652
Moderna
MRNA
$21.8B
$254K 0.01%
1,001
-58
-5% -$17K
TECH icon
653
Bio-Techne
TECH
$11.2B
$254K 0.01%
1,960
-68
-3% -$8.34K
CGO
654
Calamos Global Total Return Fund
CGO
$125M
$253K 0.01%
16,338
+6,357
+64% +$99.8K
PH icon
655
Parker-Hannifin
PH
$123B
$253K 0.01%
795
+43
+6% +$13.3K
BNS icon
656
Scotiabank
BNS
$107B
$250K 0.01%
3,482
FXZ icon
657
First Trust Materials AlphaDEX Fund
FXZ
$368M
$250K 0.01%
4,014
-3,008
-43% -$181K
IQV icon
658
IQVIA
IQV
$38.7B
$248K 0.01%
880
+292
+50% +$75.8K
RDIV icon
659
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
$247K 0.01%
5,853
-70
-1% -$2.84K
FE icon
660
FirstEnergy
FE
$28B
$246K 0.01%
5,920
-1,726
-23% -$66.5K
FHLC icon
661
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$246K 0.01%
3,581
-344
-9% -$22.6K
STZ icon
662
Constellation Brands
STZ
$22.2B
$245K 0.01%
976
-233
-19% -$53.1K
SWKS icon
663
Skyworks Solutions
SWKS
$9.37B
$243K 0.01%
1,566
-53
-3% -$8.48K
AZN icon
664
AstraZeneca
AZN
$263B
$242K 0.01%
2,079
+38
+2% +$4.47K
CE icon
665
Celanese
CE
$4.9B
$242K 0.01%
1,437
-105
-7% -$17.1K
OLN icon
666
Olin
OLN
$2.11B
$240K 0.01%
4,166
+2,330
+127% +$131K
HZNP
667
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$240K 0.01%
2,224
+132
+6% +$14.4K
MCK icon
668
McKesson
MCK
$100B
$239K 0.01%
959
-61
-6% -$13.4K
BWA icon
669
BorgWarner
BWA
$13.1B
$237K 0.01%
5,967
+3,629
+155% +$146K
AKAM icon
670
Akamai
AKAM
$16.7B
$236K 0.01%
2,013
+130
+7% +$14.3K
AFL icon
671
Aflac
AFL
$64.9B
$235K 0.01%
4,026
-61
-1% -$3.42K
EVRG icon
672
Evergy
EVRG
$19.1B
$235K 0.01%
3,427
+2,236
+188% +$145K
AFGR
673
First Trust Active Factor Large Cap Growth ETF
AFGR
$93M
$235K 0.01%
8,645
-20,461
-70% -$571K
CNC icon
674
Centene
CNC
$30.7B
$234K 0.01%
2,845
-89
-3% -$6.52K
QDF icon
675
FlexShares Quality Dividend Index Fund
QDF
$2.22B
$234K 0.01%
3,817
-17
-0.4% -$1K

Similar funds

Concourse Financial Group Securities's Q4 2021 Portfolio in Review

As of Q4 2021, Concourse Financial Group Securities held 2,523 positions worth $1.76B, up 7.5% from $1.64B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Concourse Financial Group Securities's Q4 2021 filing shows 97 new, 920 increased, 750 reduced and 126 closed positions. Its largest new stake was Abacus FCF Real Assets Leaders ETF: 333,062 shares worth $8.59M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $6.01M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 7.6% a quarter earlier, followed by Financials and Healthcare.

  • Concourse Financial Group Securities's largest Q4 2021 buy was Abacus FCF Real Assets Leaders ETF: 333,062 shares worth $8.59M.
  • Concourse Financial Group Securities added most to iShares Fallen Angels USD Bond ETF in Q4 2021, an estimated $5.07M increase.
  • Concourse Financial Group Securities's biggest Q4 2021 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $6.01M.
  • Concourse Financial Group Securities fully exited State Street SPDR ICE Preferred Securities ETF in Q4 2021, selling an estimated $5.64M.
  • Concourse Financial Group Securities's ten largest holdings make up 21% of its $1.76B portfolio in Q4 2021.
  • Concourse Financial Group Securities opened 97 new positions and closed 126 in Q4 2021.
  • Concourse Financial Group Securities's portfolio value rose 7.5% quarter-over-quarter to $1.76B.

Based on Concourse Financial Group Securities's 13F filing for Q4 2021, filed 7 Feb 2022.